Notice of Special Interest (NOSI): Small Business Digital Technologies for Early Detection, Characterization and Monitoring of Senescence-Related Changes (NOT-AG-23-004)
Sponsor: National Institute on Aging
Due Date: See announcement.
GRANTS
264 RESULTS
You searched notice-intent-publish-notice-funding-opportunity-alzheimers-clinical-trials-consortium-actc
To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.
Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.
Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) (PAR-23-112)
Sponsor: National Institutes of Health
Due Date: Multiple due dates; see announcement.
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) (PAR-23-084)
Sponsor: National Institutes of Health
Due Date: Multiple due dates; see announcement.
Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) (RFA-AG-24-001)
Sponsor: National Institute on Aging
Due Date: Multiple due dates; see announcement.
Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed) (PAR-23-073)
Sponsor: National Institutes of Health
Due Date: Multiple due dates; see announcement.
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) (PAR-23-082)
Sponsor: National Institute on Aging
Due Date: Multiple due dates; see announcement.
Notice of NINDS Specific Interest in AD/ADRD for PAS-22-196 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)" (NOT-NS-23-049)
Sponsor: National Institute of Neurological Disorders and Stroke
Notice of NINDS Specific Interest in AD/ADRD for PAS-22-197 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)" (NOT-NS-23-050)
Sponsor: National Institute of Neurological Disorders and Stroke
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) (PAR-23-057)
Sponsor: National Institute on Aging
Due Date: Multiple due dates; see announcement.
FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) (PAR-23-072)
Sponsor: Food and Drug Administration
Due Date: Multiple due dates; see announcement.
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) (PAR-23-054)
Sponsor: National Institute on Aging, Office of Research on Women's Health
Due Date: Multiple due dates; see announcement.
Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) (PAR-23-053)
Sponsor: National Institute on Aging, Office of Research on Women's Health
Due Date: Multiple due dates; see announcement.
Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) (PAR-24-022)
Sponsor: National Institutes of Health
Due Date: Multiple due dates; see announcement.
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) (PAR-23-046)
Sponsor: National Institutes of Health
Due Date: Multiple due dates; see announcement.
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) (PAR-23-047)
Sponsor: National Institutes of Health
Due Date: Multiple due dates; see announcement.
Current Filters
- Keyword: notice-intent-publish-notice-funding-opportunity-alzheimers-clinical-trials-consortium-actc x